Stanford researchers have engineered yeast strains for de novo biosynthesis of tetrahydropapaverine (THP) and a semi-synthetic production of papaverine with high efficiency.
Researchers in Dr. Christina Smolke's lab have generated novel RNA aptamer sensors that can be used to regulate gene expression in response to the clinically relevant drug folinic acid.